DAFTAR PUSTAKA 1 In: Sulistia Gan Gunawan (eds.) Farmakologi ...
-
Upload
phungnguyet -
Category
Documents
-
view
231 -
download
1
Transcript of DAFTAR PUSTAKA 1 In: Sulistia Gan Gunawan (eds.) Farmakologi ...
41
DAFTAR PUSTAKA
1 In: Sulistia Gan Gunawan (eds.) Farmakologi dan Terapi, 5th ed. Jakarta:
FK Universitas Indonesia; 2008. p230-246
2 Toms L, McQuay HJ, Derry S, Moore RA. Single Dose Oral Paracetamol
(Acetaminophen) For Postoperative Pain in Adults. The Cochrane
Collaboration. 20012;(6)
3 Adnan Asaad Abu omar, Khaled Awwad Al issa. Intravenous
paracetamol (Prefalgan) for analgesia after cesarean section. Rawal
Medical Journal.2011;36(4)
4 J. A. Alhashemi and M. F. Daghistani. Effects of intraoperative i.v
acetaminophen vs i.m meperidine on post-tonsillectomy pain in children.
British Journal of Anaesthesia.2006;(6)
5 Heirmayani. Toksikopatologi Hati Mencit Pada Pemberian Parasetamol.
IPB. 2007
6 Paramita, P. Kadar Serum Aspartat Aminotransferase dan Alanin
Aminotransferase Pada Tikus Wistar Setelah Pemberian Asetaminofen
Per Oral Dalam Berbagai Dosis. Semarang: UNDIP. 2007
7 Moynihan, R. FDA fails to reduce accessibility of paracetamol despite
450 deaths a year. BMJ; 2002. p325-678
8 Siker BPOM. Data keracunan parasetamol di Indonesia tahun 2002-
2005.BPOM. 2006
9 Soenarjo (eds.). Anestesiologi. Semarang: IDSAI Cabang Jawa Tengah.
2002; p295-309
42
10 Sherlock, S. Penyakit Hati dan Sistem Saluran Empedu. Jakarta: Widya
Medika. 1995;p145-167
11 Departemen Pendidikan Nasional. Kamus Besar Bahasa Indonesia
[internet]. [cited 2013 februari 9]. Available from:
http://bahasa.kemdiknas.go.id/kbbi/index.php Susilaningsih,
12 Boulton, T.B. Anestesiologi, Edisi 10. Jakarta: EGC. 2004;p120-122
13 Latief, S.A. et al. Petunjuk Praktis Anestesiologi. Jakarta: Bag.
Anestesiologi dan Terapi intensif FK UI. 2002;p86-90
14 Katzung, B.G. Farmakologi Dasar dan Klinik. Jakarta: Salemba Medika.
2004;p479-489
15 Dorland. Kamus Kedokteran Dorland. Jakarta: EGC. 2008;p.(n)
16 Price, S.A et al. Patofisiologi vol. 1. Jakarta: EGC. 2005;p457-515
17 Bagian Anatomi. Situs Abdominis. Semarang: Bagian Anatomi, Fakultas
Kedokteran Universitas Diponegoro
18 Leeson S.T. et al. Buku Ajar Histologi. Jakarta: EGC. 2003
19 Neni. Lecture Notes Histologi 2. Semarang: Bagian Histologi Fakultas
Kedokteran UNDIP. 2010
20 Aru W dkk. Ilmu Penyakit Dalam Jilid 1 Edisi V. Jakarta:
InternaPublishing. 2009;p640-688
21 Marshall, W. Alanine Aminotranferase (Serum, Plasma). The Association
for Clinical Biochemistry. 2012
22 Guyton and Hall. Textbook Of Medical Physiology. Jakarta:EGC.1997;
23 Girindra A. Patologi Klinik. Bogor:IPB. 1986
43
24 Frank C. Toksikologi Dasar, Edisi 2. Jakarta: Balai Penerbit FK UI.
1995;p111-113
25 Julita, I. Aspek Farmakokinetik Klinik Beberapa Obat Berpotensi
Hepatotoksik Pada Pasien Rawat Inap di Bangsal Paru RSUP Dr. M.
Djamil Padang.2011
26 World Health Organization (WHO). General Guidelines for
Methodologies on Research and Evaluation of Traditional Medicine.
Geneva: WHO. 2000
27 Laurence, D.R. et al. Evaluation of Drug Activities. London: Academic
Press.1964
28 LeeWM, Ostapowicz G. Acetaminophen : Pathology and
clinicalpresentations of hepatotoxicity. In: Kaplowitz N, DeLeve LD,
editors. DrugInduced Liver Injury. Informa Healthcare USA, 2007
29 Nelson SD, Bruschi SA. Mechanisms of acetaminophen induced
liverdamage. In: Kaplowitz N, DeLeve LD, editors. Drug Induced Liver
Injury.Informa Healthcare USA, 2007
30 MedlinePlus [internet]. United State: SGPT/ALT; 2011 [update 2013 Feb
2; cited 2013 Jul 31]. Available from: http://www.webmd.com/digestive-
disorders/alanine-aminotransferase-alt?page=2
31 E, Kosasih dan A.S Kosasih. Tafsiran hasil pemeriksaan laboratorium
klinik, Edisi 2. Tangerang: Karishma Publishing Group; 2008;p150-152
LAMPIRAN
44
LAMPIRAN 1. ETHICAL CLEARANCE
LAMPIRAN 2. SURAT IJIN PENELITIAN
45
LAMPIRAN 3. HASIL PENELITIAN
46
Case Processing Summary
Descriptives
pemberian parasetamol Statistic Std. Error
kadar SGPT
KONTROL Mean 67.780 3.1080
95% Confidence Interval for Mean
Lower Bound 59.151
Upper Bound 76.409
5% Trimmed Mean 67.794
Median 68.500
Variance 48.297
Std. Deviation 6.9496
Minimum 59.7
Maximum 75.6
Range 15.9
Interquartile Range 13.7
Skewness -.117 .913
Kurtosis -2.529 2.000
PERLAKUAN 1 Mean 90.540 7.3971
95% Confidence Interval for Mean
Lower Bound 70.002
Upper Bound 111.078
5% Trimmed Mean 90.544
Median 95.700
Variance 273.588
Std. Deviation 16.5405
Minimum 71.5
Maximum 109.5
Range 38.0
Interquartile Range 31.9
pemberian parasetamol
Cases
Valid Missing Total
N Percent N Percent N Percent
kadar SGPT
KONTROL 5 100.0% 0 .0% 5 100.0%
PERLAKUAN 1 5 100.0% 0 .0% 5 100.0%
PERLAKUAN 2 5 100.0% 0 .0% 5 100.0%
47
pemberian parasetamol
PERLAKUAN 2PERLAKUAN 1KONTROL
kad
ar
SG
PT
120.0
100.0
80.0
60.0
11
Skewness -.232 .913
Kurtosis -2.494 2.000
PERLAKUAN 2 Mean 98.560 9.2999
95% Confidence Interval for Mean
Lower Bound 72.739
Upper Bound 124.381
5% Trimmed Mean 99.644
Median 107.700
Variance 432.443
Std. Deviation 20.7953
Minimum 63.2
Maximum 114.4
Range 51.2
Interquartile Range 32.4
Skewness -1.750 .913
Kurtosis 3.053 2.000
Tests of Normality
pemberian parasetamol
Kolmogorov-Smirnov(a) Shapiro-Wilk
Statistic df Sig. Statistic df Sig.
kadar SGPT
KONTROL .205 5 .200(*) .922 5 .540
PERLAKUAN 1 .225 5 .200(*) .906 5 .442
PERLAKUAN 2 .270 5 .200(*) .804 5 .087
* This is a lower bound of the true significance. a Lilliefors Significance Correction
48
Test of Homogeneity of Variances
kadar SGPT
Levene Statistic df1 df2 Sig.
1.850 2 12 .199
ANOVA
kadar SGPT
Sum of
Squares df Mean Square F Sig.
Between Groups 2549.577 2 1274.789 5.070 .025
Within Groups 3017.312 12 251.443
Total 5566.889 14
Post Hoc Tests Multiple Comparisons
Dependent Variable: kadar SGPT LSD
(I) pemberian parasetamol
(J) pemberian parasetamol
Mean Difference (I-
J) Std. Error Sig.
95% Confidence Interval
Lower Bound Upper Bound
Lower Bound
Upper Bound
Lower Bound
KONTROL PERLAKUAN 1 -22.7600(*) 10.0288 .042 -44.611 -.909
PERLAKUAN 2 -30.7800(*) 10.0288 .010 -52.631 -8.929
PERLAKUAN 1 KONTROL 22.7600(*) 10.0288 .042 .909 44.611
PERLAKUAN 2 -8.0200 10.0288 .439 -29.871 13.831
PERLAKUAN 2 KONTROL 30.7800(*) 10.0288 .010 8.929 52.631
PERLAKUAN 1 8.0200 10.0288 .439 -13.831 29.871
* The mean difference is significant at the .05 level.
LAMPIRAN 4. DOKUMENTASI
49
50
51
LAMPIRAN 5. DAFTAR RIWAYAT HIDUP
Identitas
Nama : Indra Kusuma
NIM : G2A009128
Tempat, Tanggal lahir : Rembang, 27 November 1991
Jenis Kelamin : Laki-laki
Alamat : Ds. Soditan RT : 03/ II Lasem Kab. Rembang
Nomor Telepon : (0295) 531306
Nomor HP : 08811080222
e-mail : [email protected]
Riwayat Pendidikan Formal
1. SD : MI-ANNASHRIYAH Lulus tahun : 2003
2. SMP : SMP N 1 LASEM Lulus tahun : 2006
3. SMA : SMA N 2 REMBANG Lulus tahun : 2009
4. FK UNDIP : Masuk tahun : 2009
Keanggotaan Organisasi
1. Ketua Jaringan Mahasiswa Kesehatan Indonesia Tahun 2011 s/d 2012
2. Wakil Ketua Medical Creative Arts Tahun 2010 s/d 2012
3. Staff Bidang Ekonomi Usaha dan Investasi Tahun 2010 s/d 2011